A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase

Analytical Biochemistry

Volumn 412, Issue 1, 2011, Pages 18-25

  Zhang, Ruo Yu ^a   Qin, Ye ^a   Lv, Xiao Qun ^a   Wang, Pei ^a   Xu, Tian Ying ^a   Zhang, Lei ^a   Miao, Chao Yu ^a,b,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Enzyme activity assay; High throughput screening; NAD; Nampt; NMN

Indexed keywords

BIOCHEMISTRY; DIAGNOSIS; ENZYME ACTIVITY; MAMMALS; TUMORS;

EXPERIMENTAL EVIDENCE; HIGH THROUGHPUT SCREENING; NAMPT; NICOTINAMIDE ADENINE DINUCLEOTIDES; NICOTINAMIDE MONONUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROANGIOGENIC ACTIVITIES; RATE-LIMITING ENZYMES;

DRUG PRODUCTS;

DAPORINAD; ENZYME INHIBITOR; FLAVONE DERIVATIVE; GALLOTANINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FLUOROMETRY; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL;

MAMMALIA;

EID: 79952439080     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.12.035     Document Type: Article

References (51)

1. W.T. Penberthy Nicotinamide adenine dinucleotide biology and disease Curr. Pharm. Des. 15 2009 1 2
2. + metabolism in health and disease Trends Biochem. Sci. 32 2007 12 19 (Pubitemid 46038737)
3. D. D'Amours, S. Desnoyers, I. D'Silva, and G.G. Poirier Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions Biochem. J. 342 1999 249 268 (Pubitemid 29425344)
4. M.C. Haigis, and L.P. Guarente Mammalian sirtuins: emerging roles in physiology, aging, and calorie restriction Genes Dev. 20 2006 2913 2921 (Pubitemid 44771725)
5. L.R. Saunders, and E. Verdin Sirtuins: critical regulators at the crossroads between cancer and aging Oncogene 26 2007 5489 5504 (Pubitemid 47255930)
6. S.J. Lin, and L. Guarente Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity, and disease Curr. Opin. Cell Biol. 15 2003 241 246 (Pubitemid 36332200)
7. G. Magni, A. Amici, M. Emanuelli, G. Orsomando, N. Raffaelli, and S. Ruggieri Enzymology of NAD plus homeostasis in man Cell. Mol. Life Sci. 61 2004 19 34 (Pubitemid 38121897)
8. + synthesis Adv. Enzymol. Relat. Areas Mol. Biol. 73 1999 135 182
9. A. Rongvaux, F. Andris, F. Van Gool, and O. Leo Reconstructing eukaryotic NAD metabolism BioEssays 25 2003 683 690 (Pubitemid 36850796)
10. P.R. Martin, R.J. Shea, and M.H. Mulks Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence J. Bacteriol. 183 2001 1168 1174 (Pubitemid 32107712)
11. J.R. Revollo, A.A. Grimm, and S. Imai The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J. Biol. Chem. 279 2004 50754 50763 (Pubitemid 40017813)
12. + levels dictate cell survival Cell 130 2007 1095 1107 (Pubitemid 47410271)
13. W. Zhang, Y. Xie, T. Wang, J. Bi, H. Li, L.Q. Zhang, S.Q. Ye, and S. Ding Neuronal protective role of PBEF in a mouse model of cerebral ischemia J. Cereb. Blood Flow Metab. 30 2010 1962 1971
14. P.O. Hassa, S.S. Haenni, M. Elser, and M.O. Hottiger Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol. Mol. Biol. Rev. 70 2006 789 829 (Pubitemid 44484693)
15. L. Yalcintepe, L. Turker-Sener, A. Sener, G. Yetkin, D. Tiryaki, and E. Bermek Changes in metabolism NAD/ADP-ribose in rectal cancer Braz. J. Med. Biol. Res. 38 2005 361 365 (Pubitemid 40485175)
16. W.X. Zong, D. Ditsworth, D.E. Bauer, Z.Q. Wang, and C.B. Thompson Alkylating DNA damage stimulates a regulated form of necrotic cell death Genes Dev. 18 2004 1272 1282 (Pubitemid 38720595)
17. S.E. Hufton, P.T. Moerkerk, R. Brandwijk, A.P. de Bruine, J.W. Arends, and H.R. Hoogenboom A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization FEBS Lett. 463 1999 77 82 (Pubitemid 30001722)
18. J.R. van Beijnum, P.T.M. Moerkerk, A.J. Gerbers, A.P. de Brune, J.W. Arends, H.R. Hoogenboom, and S.E. Hufton Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer Biochim. Biophys. Acta 101 2002 118 127 (Pubitemid 34970903)
19. P.S. Reddy, S. Umesh, B. Thota, A. Tandon, P. Pandey, A.S. Hegde, A. Balasubramaniam, B.A. Chandramouli, V. Santosh, M.R.S. Rao, P. Kondaiah, and K. Somasundaram PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value Cancer Biol. Ther. 7 2008 663 668
20. S.R. Kim, S.K. Bae, K.S. Choi, S.Y. Park, H.O. Jun, J.Y. Lee, H.O. Jang, I. Yun, K.H. Yoon, Y.J. Kim, M.A. Yoo, K.W. Kim, and M.K. Bae Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2 Biochem. Biophys. Res. Commun. 357 2007 150 156 (Pubitemid 46574511)
21. R. Adya, B.K. Tan, A. Punn, J. Chen, and H.S. Randeva Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: Novel insights into visfatin-induced angiogenesis Cardiovasc. Res. 78 2008 356 365 (Pubitemid 351556097)
22. A. Garten, S. Petzold, A. Korner, S. Imai, and W. Kiess Nampt: Linking NAD biology, metabolism, and cancer Trends Endocrinol. Metab. 20 2009 130 138
23. J.A. Khan, F. Forouhar, X. Tao, and L. Tong Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery Expert Opin. Ther. Targets 11 2007 695 705 (Pubitemid 46730083)
24. U.H. Olesen, A.V. Thougaard, P.B. Jensen, and M. Sehested A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor Mol. Cancer Ther. 9 2010 1609 1617
25. P. Beauparlant, D. Bedard, C. Bernier, H. Chan, K. Gilbert, D. Goulet, M.O. Gratton, M. Lavoie, A. Roulston, E. Turcotte, and M. Watson Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777 Anticancer Drugs 20 2009 346 354
26. + biosynthesis: Strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors Mol. Cell. Biol. 29 2009 5872 5888
27. J. Preiss, and P. Handler Biosynthesis of diphosphopyridine nucleotide: 1. Identification of intermediates J. Biol. Chem. 233 1958 488 492
28. J.W. Gross, M. Rajavel, and C. Grubmeyer Kinetic mechanism of nicotinic acid phosphoribosyltransferase: implications for energy coupling Biochemistry 37 1998 4189 4199 (Pubitemid 28166441)
29. + levels J. Biol. Chem. 277 2002 18881 18890 (Pubitemid 34952448)
30. K. Holen, L.B. Saltz, E. Hollywood, K. Burk, and A.R. Hanauske The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor Invest. New Drugs 26 2008 45 51
31. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl Cancer Inst. 82 1990 1107 1112 (Pubitemid 20213250)
32. P.J.V. Hjarnaa, E. Jonsson, S. Latini, S. Dhar, R. Larsson, E. Bramm, T. Skov, and L. Binderup CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo Cancer Res. 59 1999 5751 5757
33. L.A. Skelton, M.G. Ormerod, J.C. Titley, and A.L. Jackman Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action Cytometry 33 1998 56 66 (Pubitemid 28376586)
34. K. Wosikowski, K. Mattern, I. Schemainda, M. Hasmann, B. Rattel, and R. Loser WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells Cancer Res. 62 2002 1057 1062 (Pubitemid 34160287)
35. M. Hasmann, and I. Schemainda FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis Cancer Res. 63 2003 7436 7442 (Pubitemid 37413486)
36. 31P magnetic resonance spectroscopy Clin. Cancer Res. 11 2005 3503 3513 (Pubitemid 40627905)
37. G.B. Kang, M.H. Bae, M.K. Kim, I. Im, Y.C. Kim, and S.H. Eom Crystal structure of Rattus norvegicus visfatin/PBEF/Nampt in complex with an FK866-based inhibitor Mol. Cells 27 2009 667 671
38. A. Ravaud, T. Cerny, C. Terret, J. Wanders, B.N. Bui, D. Hess, J.P. Droz, P. Fumoleau, and C. Twelves Phase I study and pharmacokinetic of CHS-828, a guanidine-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study Eur. J. Cancer 41 2005 702 707 (Pubitemid 40342552)
39. A. von Heideman, A. Berglund, R. Larsson, and P. Nygren Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data Cancer Chemother. Pharmacol. 65 2009 1165 1172
40. M.G. Rowlands, Y.M. Newbatt, C. Prodromou, L.H. Pearl, P. Workman, and W. Aherne High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity Anal. Biochem. 327 2004 176 183 (Pubitemid 38402186)
41. J.H. Zhang, T.D.Y. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73 (Pubitemid 29278954)
42. H. Nakamura, and Z. Tamura Fluorometric assay of α-methylene carbonyl compounds with N-methylnicotinamide chloride Anal. Chem. 50 1978 2047 2051
43. A. Sano, and H. Nakamura Fluorometric determination of N-nitroso-N-methylurea with nicotinamide and acetophenone Anal. Sci. 17 2001 375 378 (Pubitemid 32280321)
44. +: application to the high-throughput screening of small molecules as potential inhibitors Anal. Biochem. 326 2004 78 86 (Pubitemid 38177485)
45. L. Formentini, F. Moroni, and A. Chiarugi Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo Biochem. Pharmacol. 77 2009 1612 1620
46. L Anal. Biochem. 307 2002 70 75
47. G.W. Aherne, M. Garrett, E. McDonald, and P. Workman Mechanism-based high-throughput screening for novel anticancer drug discovery B.C. Baguley, Anti-Cancer Drug Design 2002 Academic Press San Diego 249 267
48. A. Rongvaux, R.J. Shea, M.H. Mulks, D. Gigot, J. Urbain, O. Leo, and F. Andris Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis Eur. J. Immunol. 32 2002 3225 3234 (Pubitemid 35414880)
49. G.C. Elliott, J. Ajioka, and C.Y. Okada A rapid procedure for assaying nicotinamide phosphoribosyltransferase Anal. Biochem. 107 1980 199 205 (Pubitemid 11196643)
50. M. Rocchigiani, V. Micheli, J.A. Duley, and H.A. Simmonds Determination of nicotinamide phosphoribosyltransferase activity in human erythrocytes - high-performance liquid chromatography-linked method Anal. Biochem. 205 1992 334 336
51. P. Wang, T.Y. Xu, Y.F. Guan, D.F. Su, G.R. Fan, and C.Y. Miao Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide Cardiovasc. Res. 81 2009 370 380